ArunA Biomedical, Inc.

32 articles about ArunA Biomedical, Inc.

• Aruna Bio Announces Presentation on Treatment Opportunities for its Neural Exosome Platform and Lead Program, AB126 at the Exosome Based Therapeutic Development Summit

  9/5/2023

  Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced an oral presentation at the Exosome Based Therapeutic Development Summit, being held in Boston, MA from September 5-7, 2023.

• Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Receives Entrepreneur Distinction from The University System of Georgia Board of Regents

  3/28/2023

  Aruna Bio, Inc. announced that the Company’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, has been named one of the first recipients of Entrepreneur Distinction from The University System of Georgia Board of Regents.

• Aruna Bio Announces Issuance of a New Composition of Matter Patent Covering Neural Exosomes in Japan

  6/13/2022

  Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, announced that the Japan UPSC UENO Patent Office has issued a patent, No. 7075594, to Aruna Bio and the University of Georgia Research Foundation allowing broad claims on the composition of neural exosomes and their use as a therapeutic for neurological diseases and disorders.

• Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury

  5/31/2022

  Aruna Bio, Inc. announced that it has received funding from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health of Health to advance AB126™, a multimodal neuroprotective and regenerative neural stem cell extracellular vesicle product, to treat Traumatic Brain Injury.

• Aruna Bio Appoints Stephen From As Chief Executive Officer

  4/27/2022

  Aruna Bio, a leader in the development of neural exosomes for the treatment of neuro-inflammatory and neurodegenerative diseases, announced the appointment of Stephen From as Chief Executive Officer.

• Aruna Bio to Present at the Piper Sandler 33rd Annual Healthcare Conference

  11/22/2021

  Aruna Bio, Inc. today announced that Dr. Mark A. Sirgo, Chief Executive Officer, will be presenting at the Piper Sandler 33rd Annual Virtual Healthcare Conference. 

• Aruna Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference and the Oppenheimer Healthcare Life Sciences & MedTech Summit

  9/8/2021

  Aruna Bio, Inc. today announced that Dr. Mark A. Sirgo , Chief Executive Officer, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13

• Aruna Bio to Present at the Jefferies 2020 Healthcare ConferenceVirtual presentation scheduled for 1:00 PM on June 3 and will be accessible via webcast

  5/26/2020

  Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, announced that Dr. Mark Sirgo, Chief Executive Officer, will be presenting at the Jefferies 2020 Healthcare Conference on Wednesday, June 3rd at 1:00 PM Eastern Time.

• Aruna Bio Appoints Dr. James Paskavitz as Vice President of Research and Development

  12/4/2019

  Dr. Paskavitz has over fifteen prior years of clinical experience including outpatient treatment of neurodegenerative diseases and inpatient intensive care neurology.

• Aruna Bio to Present at the 31st Annual Piper Jaffray Healthcare Conference and will be accessible via webcast

  11/21/2019

  Aruna Bio, Inc. announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief Scientific Officer, will be presenting at the 31st Annual Piper Jaffray Healthcare Conference in New York City on Thursday, December 5th at a new time of 9:30 AM Eastern Time.

• Aruna Bio Appoints Dr. Renee Boerner as Vice President of Regulatory Affairs

  11/13/2019

  Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, announced the appointment of Renee Boerner, PhD, as Vice President of Regulatory Affairs.

• Aruna Bio to Present at Exosome Based Therapeutic Development Summit

  9/12/2019

  Presentation will highlight the potential utilization of exosomes as a therapeutic and delivery vehicle for treating neurodegenerative diseases

• ArunA Bio Appoints Tony Townley to Board of Directors

  8/8/2019

  ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, announced the addition of Tony Townley to its Board of Directors.

• ArunA Bio Raises $13 Million in Common Stock Financing

  7/24/2019

  Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities

• ArunA Bio to Provide Corporate Update and Participate on a Panel at the 2019 BIO International Convention

  5/22/2019

  Panel Discussion Will Highlight Impact of Exosomes as Therapeutics and Drug Delivery Vehicles 

• ArunA Bio Appoints Al Medwar as Executive Vice President, Corporate and Commercial Development

  3/18/2019

  ArunA Bio, a leader in the development of exosomes and exosome therapeutics for the treatment of neurodegenerative disorders, announced the appointment of Al Medwar as Executive Vice President, Corporate and Commercial Development.

• ArunA Bio Appoints Dr. Mark Sirgo as Chief Executive Officer

  1/15/2019

  Dr. Steven Stice to Continue Leading Company’s Research and Manufacturing Operations

• ArunA Biomedical to Present and Participate on a Panel at 2018 BIO International Convention

  5/24/2018

  ArunA Biomedical today announced that Steven Stice, Ph.D., co-founder, chief executive and chief scientific officer, will present a corporate update and participate on a panel at the 2018 BIO International Convention occurring June 4-7, 2018 in Boston, MA.

• ArunA Biomedical Announces Oral Presentation of Preclinical Data at ISEV 2018

  4/25/2018

  ArunA Biomedical announced it will present data at the 2018 International Society for Extracellular Vesicles (ISEV) Annual Meeting occurring May 2-6 in Barcelona, Spain.

• ArunA Biomedical Announces Publication of Study in Stroke that Reports Exosomes Improved Tissue and Functional Recovery in Pig Model of Ischemic Stroke

  4/12/2018

  First company to demonstrate proof-of-concept of the therapeutic potential of extracellular vesicles in two divergent animal species and two stroke types